Resume of CEO

March, 1974: Graduated from Nara Unebi High School, Japan
March, 1978: B.S.: College of Engineering, Osaka University, Japan; Major in Petrochemistry
March, 1980: M.S.: College of Engineering, Osaka University, Japan; Major in Process Engineering
April, 1980: Joined Kanebo Inc. (Institute of Pharmacology, Research and Planning Department)
In charge of Dermatology related new drug R&D
October, 1989: Visiting scholar to Department of Pharmacology, Cancer Research Institute, Manchester University, U.K.;
Department of Dermatology, School of Medicine, University of Pittsburgh, USA;
Department of Dermatology, University of Virginia, USA for the R&D of anti-keloid drug.
August, 1997: Resigned from Kanebo Inc.
April, 2000: Graduate Student of Kobe Pharmaceutical University
May, 2001: CEO, NeoChemir Ltd
March, 2002: CEO, NeoChemir Inc.

Main patent applications in Kanebo: ・ Anti-keloid drugs
・ Inhalants for colds
・ Wound covering materials
May, 1982-: Anti-keloid drug development from human placenta together with Dr. Ozaki et al (Head surgeon of Tanaka Hospital in Hyogo Prefecture)
September, 1983-: Synthetic anti-keloid drugs development together with Dr. Ohya et al (Head surgeon of Japan Second Red Cross Hospital in Kyoto)
April 1992-: Wound covering material development with Professor Okumura (Department of Pharmacology, Kobe University)